Epithelial ovarian cancer: evolution of management in the era of precision medicine

S Lheureux, M Braunstein… - CA: a cancer journal for …, 2019 - Wiley Online Library
Ovarian cancer is the second most common cause of gynecologic cancer death in women
around the world. The outcomes are complicated, because the disease is often diagnosed …

Nanotechnology in ovarian cancer: Diagnosis and treatment

M Barani, M Bilal, F Sabir, A Rahdar, GZ Kyzas - Life Sciences, 2021 - Elsevier
To overcome the drawbacks of conventional delivery, this review spotlights a number of
nanoscale drug delivery systems, including nanoparticles, liposomes, nano micelles …

NCCN guidelines® insights: Ovarian cancer, version 3.2022: Featured updates to the NCCN guidelines

DK Armstrong, RD Alvarez, FJ Backes… - Journal of the National …, 2022 - jnccn.org
Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the
United States, with less than half of patients living> 5 years following diagnosis. The NCCN …

Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology

DK Armstrong, RD Alvarez, JN Bakkum-Gamez… - Journal of the National …, 2021 - jnccn.org
Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the
United States and is the country's fifth most common cause of cancer mortality in women. A …

Ovarian cancer statistics, 2018

LA Torre, B Trabert, CE DeSantis… - CA: a cancer journal …, 2018 - Wiley Online Library
In 2018, there will be approximately 22,240 new cases of ovarian cancer diagnosed and
14,070 ovarian cancer deaths in the United States. Herein, the American Cancer Society …

Outcomes from opportunistic salpingectomy for ovarian cancer prevention

GE Hanley, CL Pearce, A Talhouk, JS Kwon… - JAMA network …, 2022 - jamanetwork.com
Importance Opportunistic salpingectomy (OS), which is the removal of fallopian tubes during
hysterectomy or instead of tubal ligation without removal of ovaries, is recommended to …

Cell origins of high-grade serous ovarian cancer

J Kim, EY Park, O Kim, JM Schilder, DM Coffey… - Cancers, 2018 - mdpi.com
High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is
the most common and deadliest type of ovarian cancer. HGSC appears to arise from the …

Endometriosis typology and ovarian cancer risk

ME Barnard, LV Farland, B Yan, J Wang, B Trabert… - Jama, 2024 - jamanetwork.com
Importance Endometriosis has been associated with an increased risk of ovarian cancer;
however, the associations between endometriosis subtypes and ovarian cancer histotypes …

[HTML][HTML] Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment

E Schoutrop, L Moyano-Galceran, S Lheureux… - Seminars in cancer …, 2022 - Elsevier
Ovarian cancer encompasses a heterogeneous group of malignancies that involve the
ovaries, fallopian tubes and the peritoneal cavity. Despite major advances made within the …

Spatial transcriptomics depict ligand–receptor cross-talk heterogeneity at the tumor-stroma interface in long-term ovarian cancer survivors

S Ferri-Borgogno, Y Zhu, J Sheng, JK Burks, JA Gomez… - Cancer research, 2023 - AACR
Advanced high-grade serous ovarian cancer (HGSC) is an aggressive disease that
accounts for 70% of all ovarian cancer deaths. Nevertheless, 15% of patients diagnosed …